Hemmingsen
Allan G. Hemmingsen, Jystrup DK
Patent application number | Description | Published |
---|---|---|
20100160956 | REMOVABLE VENA CAVA FILTER FOR REDUCED TRAUMA IN COLLAPSED CONFIGURATION - The present invention provides a method of capturing thrombi in a blood vessel, which includes delivering a removable filter in a collapsed state within the blood vessel and deploying the filter to an expanded state within the blood vessel. The filter includes a plurality of primary struts and a plurality of secondary struts emanating from a hub and extending arcuately along a longitudinal axis and linearly radially. Each primary strut has an arcuate segment including first and second curved portions. Each secondary strut includes first and second arcs. The primary struts terminate with an anchoring hook. Each primary strut crosses another primary strut along the longitudinal axis in the collapsed state such that the arcuate segments occupy a first diameter and the anchoring hooks occupy a second diameter, the first diameter being greater than the second diameter for filter retrieval or delivery. In the expanded state, the secondary struts centralize the filter in the blood vessel and the anchoring hooks engage with the blood vessel. | 06-24-2010 |
Allan G. Hemmingsen, Jvstrup M. DK
Patent application number | Description | Published |
---|---|---|
20090076585 | Device for loading a self-expandable prosthesis into a sheath - An assembly comprising: a protective sheath and a loading device for loading a self-expandable prosthesis into said sheath, the loading device having a conical distal section, which radially compresses the prosthesis and an annular lip that engages with the interior of the distal end of said sheath to guide the prosthesis into the sheath whilst protecting the sheath from damage. | 03-19-2009 |
Allan G. Hemmingsen, Jystrup M. DK
Patent application number | Description | Published |
---|---|---|
20120259403 | DEVICE FOR LOADING A SELF EXPANDABLE PROSTHESIS INTO A SHEATH - An assembly comprising: a protective sheath and a loading device for loading a self-expandable prosthesis into said sheath, the loading device having a conical distal section, which radially compresses the prosthesis and an annular lip that engages with the interior of the distal end of said sheath to guide the prosthesis into the sheath whilst protecting the sheath from damage. | 10-11-2012 |
Austin Hemmingsen, Sioux Falls, SD US
Patent application number | Description | Published |
---|---|---|
20130019643 | MULTI-POINT LOCK HAVING SEQUENTIALLY-ACTUATED LOCKING ELEMENTS - A lock includes a deadbolt assembly having a deadbolt and a deadbolt actuator. The lock also includes a latch assembly discrete from the deadbolt assembly. The latch assembly includes a shoot bolt and a shoot bolt actuator. A blocking element may block actuation of the shoot bolt from an unlocked position to a locked position when the deadbolt is in a retracted position. Alternatively or additionally, the blocking element may block actuation of the shoot bolt from a locked position to an unlocked position when the deadbolt is in an extended position. | 01-24-2013 |
20140060127 | PASSIVE DOOR LOCK MECHANISMS - A lock mechanism for an inactive door includes a housing configured to receive a locking element from an active door lock. A slide is movably received in the housing and includes a drive bar connection element, wherein when the slide is in an unlocked position, the drive bar connection element is located in a path of travel of the deadbolt, and wherein when the slide is in a locked position, the drive bar connection element is located outside the path of travel of the deadbolt. At least one drive bar at least partially received in the housing and is connected to the drive bar connection element. The drive bar is actuated by an actuator located remote from the housing. A blocking element located within the housing, wherein the blocking element prevents movement of the slide from the locked position to the unlocked position. | 03-06-2014 |
Brock Hemmingsen, Tega Cay, SC US
Patent application number | Description | Published |
---|---|---|
20110011668 | SEISMIC WAVE GENERATING APPARATUS AND METHOD - A seismic wave generating device and methods for generating seismic waves having a relatively strong longitudinal energy and a relatively weak transverse energy are disclosed. A device may have a hollow casing and a striking member passing through the hollow casing, the striking member or the hollow casing bearing a spacing member. A method may drive the hollow casing into the earth, then remove earth from within the hollow casing. The method may place a striking member through the hollow casing and may drive the striking member further into the earth to create seismic waves with a relatively strong longitudinal energy and a relatively weak transverse energy. | 01-20-2011 |
Eric Troy Hemmingsen, San Pablo, CA US
Patent application number | Description | Published |
---|---|---|
20140299558 | WATER DECANTING BARREL - Processes and apparatus for rapidly and efficiently removing liquid from a catalyst slurry comprising catalyst particles. A decanting barrel for dewatering the catalyst slurry may comprise a barrel body having a perforated portion, a reservoir in fluid communication with the perforated portion, and an evacuation conduit in fluid communication with the reservoir. In a process for removing the liquid from the catalyst slurry, the decanting barrel may be disposed in a container, the catalyst slurry may be added to the container, the liquid may be transferred from the catalyst slurry to the reservoir via the perforated portion of the barrel body, and the liquid may be removed from the reservoir via the evacuation conduit. | 10-09-2014 |
Fred Hemmingsen, Kongsberg NO
Patent application number | Description | Published |
---|---|---|
20120285275 | STABILIZATION PLATFORM - Method and system for providing precise stabilization of a supporting structure for supporting at least one device used for aiming while the supporting structure is moving. MEMS gyroscope is employed for providing stabilization signals to driving means connected to said supporting structure for continuous stabilization adjustments of movements of the supporting structure. | 11-15-2012 |
Hans Hemmingsen, Birkeroed DK
Patent application number | Description | Published |
---|---|---|
20130267895 | Piston Rod Foot - The invention relates to a medical drug delivery apparatus which comprises a cartridge ( | 10-10-2013 |
20140350478 | Torsion-Spring Based Wind-Up Auto Injector Pen with Dial-Up/Dial-Down Mechanism - The present invention relates to an automatic torsion spring based injection device having a dial-up/dial-down mechanism by which a dose can be set by rotating a dose setting member in a first direction and which dose size can be reduced by rotating the same dose setting member in a second and opposite direction. The dial-up/dial-down mechanism operates a torsion spring which is strained when setting a dose and unstained when rotating the dose setting element in the second direction. In order to secure the torsion spring when strained, a ratchet arm ( | 11-27-2014 |
Iben Hemmingsen, Vanloese DK
Patent application number | Description | Published |
---|---|---|
20120178922 | Solid Carrageenan Ion Exchange - Embodiments of the present invention function to modify the cation concentration of carrageenans using an ion-exchange process. Processes for modifying the cation concentrations of solid carrageenans are provided. The processes include treating solid carrageenan with an aqueous treatment solution comprising an alcohol and a salt and washing the corresponding treated solid carrageenan with an aqueous solution comprising an alcohol. | 07-12-2012 |
Lisbeth Tofte Hemmingsen, Copenhagen K DK
Patent application number | Description | Published |
---|---|---|
20110237673 | Novel NIDDM Regimen - The present invention relates to the use of a short-acting oral hypoglycemic agent and to a novel regimen in the treatment of type 2 diabetes in which the endogenous secretion of insulin is stimulated in connection with meals by administering in connection with the meals a short-acting oral hypoglycaemic agent. Also, the present invention relates to a method of achieving significantly improvement in the glycaemic control by a combined use of repaglinide and metformin in NIDDM patients poorly controlled on metformin alone. | 09-29-2011 |
20120202881 | Novel NIDDM Regimen - The present invention relates to the use of a short-acting oral hypoglycemic agent and to a novel regimen in the treatment of type 2 diabetes in which the endogenous secretion of insulin is stimulated in connection with meals by administering in connection with the meals a short-acting oral hypoglycaemic agent. Also, the present invention relates to a method of achieving significantly improvement in the glycaemic control by a combined use of repaglinide and metformin in NIDDM patients poorly controlled on metformin alone. | 08-09-2012 |
20130030053 | NOVEL NIDDM REGIMEN - The present invention relates to the use of a short-acting oral hypoglycemic agent and to a novel regimen in the treatment of type 2 diabetes in which the endogenous secretion of insulin is stimulated in connection with meals by administering in connection with the meals a short-acting oral hypoglycaemic agent. Also, the present invention relates to a method of achieving significantly improvement in the glycaemic control by a combined use of repaglinide and metformin in NIDDM patients poorly controlled on metformin alone. | 01-31-2013 |
20130184350 | Novel NIDDM Regimen - The present invention relates to the use of a short-acting oral hypoglycemic agent and to a novel regimen in the treatment of type 2 diabetes in which the endogenous secretion of insulin is stimulated in connection with meals by administering in connection with the meals a short-acting oral hypoglycaemic agent. Also, the present invention relates to a method of achieving significantly improvement in the glycaemic control by a combined use of repaglinide and metformin in NIDDM patients poorly controlled on metformin alone. | 07-18-2013 |
Lisbeth Tofte Hemmingsen, Copenhagen DK
Patent application number | Description | Published |
---|---|---|
20110015270 | Novel NIDDM Regimen - The present invention relates to the use of a short-acting oral hypoglycemic agent and to a novel regimen in the treatment of type 2 diabetes in which the endogenous secretion of insulin is stimulated in connection with meals by administering in connection with the meals a short-acting oral hypoglycaemic agent. Also, the present invention relates to a method of achieving significantly improvement in the glycaemic control by a combined use of repaglinide and metformin in NIDDM patients poorly controlled on metformin alone. | 01-20-2011 |
Pål Viggo Hemmingsen, Trondheim NO
Patent application number | Description | Published |
---|---|---|
20140216152 | CHARACTERIZING MULTIPHASE FLUID FLOW - A method and apparatus for determining multiphase flow characteristics inside production equipment containing at least two fluids. A pulse of heat from a heat source adjacent to the production equipment is provided, and a thermal response to the pulse is measured at each of a plurality of temperature sensors located adjacent to the production equipment. The thermal response measurement includes a time constant obtained from a measured decline in the temperature after the pulse of heat has been provided. The measured thermal responses are used to determine parameters of a fluid contained in the production equipment in proximity to each of the temperature sensors. The determined fluid parameters are in turn used to determine multiphase flow characteristics. | 08-07-2014 |
Pål Viggo Hemmingsen, Stavanger NO
Patent application number | Description | Published |
---|---|---|
20140346033 | REGENERATION OF KINETIC HYDRATE INHIBITOR - The present invention relates to a method and system for regeneration of kinetic hydrate inhibitor when it is used without a thermodynamic inhibitor. In that the use of a distillation column or tower is not needed, the present invention enables a more compact system, which also improves the possibility for heat integration of the regeneration process leading to very low energy consumption. Additional improvements over the prior art include reduced cost of buying new chemicals, reduced environmental impact because the chemicals are not discharged with the produced water and the possibility for the use of higher concentrations of kinetic hydrate inhibitor with still reduced cost and environmental impact. | 11-27-2014 |
Pernille Hoyrup Hemmingsen, Bagsvaerd DK
Patent application number | Description | Published |
---|---|---|
20080299199 | Swellable Dosage Form Comprising Gellan Gum - A novel dosage form. The dosage form is presented in particulate form and before oral ingestion the particulate material is subjected to an aqueous medium, whereby it is converted to a semi-solid form by swelling or gelling of one or more of the components, especially of a gellan gum, of the particulate matter. The invention also relates to a vehicle for oral administration of one or more active substances, the vehicle comprising a gellan gum arranged in a configuration allowing optimal water diffusion so that upon addition of a predetermined amount of an aqueous medium, without the necessity of applying shear forces or other mixing forces, within a time period of 5 minutes or less swells and/or gels and the texture of the swelled vehicle being similar to that of a soft pudding and having a viscosity of at least about 10,000 cps as measured by a Brookfield Viscometer with a #4 LV spindle at 6 rpm and at 20-25° C. In one embodiment of the invention, the particulate matter can be moulded into a desired shape or pressed onto a dispensing unit such as a spoon. | 12-04-2008 |
20100239667 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR PROLONGED EFFECT - Layered pharmaceutical composition suitable for oral use in the treatment of diseases where absorption takes place over a large part of the gastrointestinal tract. The composition comprising A) a solid inner layer comprising i) an active substance, and ii) one or more disintegrants/exploding agents, one of more effervescent agents or a mixture thereof. the solid inner layer being sandwiched between two outer layers B1) and B2), each outer layer comprising iii) a substantially water soluble and/or crystalline polymer or a mixture of substantially water soluble and/or crystalline polymers, the polymer being a polyglycol in the form of one of a) a homopolymer having a MW of at least about 100,000 daltons, and b) a copolymer having a MW of at least about 2,000 daltons, or a mixture thereof, and iv) an active substance, which is the same as in said solid inner layer A), and layer A being different from layer B, the layered composition being coated with a coating C) that has at least one opening exposing at least one surface of said outer layer, the coating being substantially insoluble in and impermeable to fluids and comprising a polymer, and the composition having a cylindrical form optionally with one or more tapered ends, wherein the ratio between the surface area of one end surface of the cylinder and the length of the cylinder is in a range of from 0.02 to 45 mm. | 09-23-2010 |
20120039969 | SWELLABLE DOSAGE FORM COMPRISING GELLAN GUM - A novel dosage form. The dosage form is presented in particulate form and before oral ingestion the particulate material is subjected to an aqueous medium, whereby it is converted to a semi-solid form by swelling or gelling of one or more of the components, especially of a gellan gum, of the particulate matter. The invention also relates to a vehicle for oral administration of one or more active substances, the vehicle comprising a gellan gum arranged in a configuration allowing optimal water diffusion so that upon addition of a predetermined amount of an aqueous medium, without the necessity of applying shear forces or other mixing forces, within a time period of 5 minutes or less swells and/or gels and the texture of the swelled vehicle being similar to that of a soft pudding and having a viscosity of at least about 10,000 cps as measured by a Brookfield Viscometer with a #4 LV spindle at 6 rpm and at 20-25° C. In one embodiment of the invention, the particulate matter can be molded into a desired shape or pressed onto a dispensing unit such as a spoon. | 02-16-2012 |
20150024048 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR PROLONGED EFFECT - Layered pharmaceutical composition suitable for oral use in the treatment of diseases where absorption takes place over a large part of the gastrointestinal tract. The composition comprising A) a solid inner layer comprising | 01-22-2015 |
Sean Mathias Hemmingsen, Saskatchewan CA
Patent application number | Description | Published |
---|---|---|
20080311629 | Development of Pcr Primers and Primer Mixtures For Amplification of Cnp60 Target Sequences - We have developed the primer pair H1511 and H1261 as a replacement for primer pair H279/H280 for specific amplification of cpn60 universal target sequences in genomic DNA or in complex DNA mixtures, including those with high G+C content. | 12-18-2008 |